Dublin, March 05, 2018 -- The "Chemical Licensing Market by Type (C1 Derivatives, C2 Derivatives, C3 Derivatives, C4 Derivatives) End-Use Industry (Oil & Gas, Chemical) & Region (North America, Europe, Asia-Pacific, Middle East & Africa, South America) - Global Forecast to 2022" report has been added to ResearchAndMarkets.com's offering.
The Chemical Licensing Market is Estimated to Be USD 10.72 Billion in 2017 and is Projected to Reach USD 13.81 Billion By 2022, at a CAGR of 5.2% from 2017 to 2022.
The increasing population, expanding manufacturing industry, and growing regulatory requirements in the chemical industry are key factors projected to drive the growth of the chemical licensing market. However, the limited adoption of chemical licensing in emerging economies, owing to the high costs of technologies, acts as a restraint to the growth of the market.
Based on end-use industry, the chemical segment is projected to grow at the highest CAGR during the forecast period. Chemical licensing caters to various industries including the base chemical, active pharmaceutical ingredient, specialty chemical, and polymer industries.
Chemical manufacturers that require C1, C2, C3, and other hydrocarbon derivatives are focused on backward integration by producing these chemicals and providing the licensing for the same, and hence need licenses to produce C1, C2, C3, and other derivatives. The global growth in industrial output is boosting the growth of the chemical industry market, which in turn, is expected to drive the growth of the chemical licensing market during the forecast period.
Based on type, the C3 segment is projected to grow at the highest CAGR from 2017 to 2022. Manufacturing C3 derivatives involves polymerization, oxidation, esterification, chlorohydrogenation, saponification, hydration, epoxidation, and oxo reaction. The demand for C3 derivatives such as polypropylene, acrylonitrile, hydrogen cyanide, acrolein, acrylic ester, and propylene oxide is increasing from end-use industries, thereby propelling the need for chemical licensing in this segment.
Market Dynamics
Drivers
- Increasing Demand for Petrochemicals in APAC
- Stringent Environmental Regulations
- Cost Optimization Strategies Implemented By Refiners
Restraints
- In-House Technology Development By End Users
Opportunities
- Increasing Refinery Capacities
- Increasing Use of New Technologies for Sustainable Manufacturing
Challenges
- Cost Optimization and High Licensing Cost
Key Topics Covered:
1 Introduction
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Industry Trends
7 Chemical Licensing Market, By Type
8 Chemical Licensing Market, By End-Use Industry
9 Chemical Licensing Market, By Region
10 Competitive Landscape
11 Company Profiles
- Chevron Phillips Chemical Company
- Eastman Chemical Company
- Exxon Mobil Corporation
- Huntsman Corporation
- Johnson Matthey
- Mitsubishi Chemical Corporation
- Mitsui Chemicals, Inc.
- Nova Chemicals Corporation
- Shell Global Solutions
- Sumitomo Chemical
For more information about this report visit https://www.researchandmarkets.com/research/hksh9w/global_chemical?w=12
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Chemicals


Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Instagram Outage Disrupts Thousands of U.S. Users
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment 



